Skip to content

Prospective Randomized Trial on Comparison of Standard- Carbon Dioxide Pressure Pneumoperitoneum Insufflators Versus AirSeal

A Prospective Randomized Trial on Comparison of Standard- Carbon Dioxide Pressure Pneumoperitoneum Insufflators Versus AirSeal

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01740011
Acronym
AirSeal
Enrollment
182
Registered
2012-12-04
Start date
2013-01-31
Completion date
2014-03-31
Last updated
2014-09-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal Disorders, Hernia, Incidence for Cholecystectomy

Brief summary

The primary objective of the present trial is to investigate, the mean operative time and to study the frequency and intensity of postoperative shoulder tip pain in patients undergoing laparoscopic surgery, i.e. cholecystectomy, colorectal surgery, hernia repair with AirSeal® compared with standard pressure CO2 insufflation systems. The primary hypothesis is that patients operated with AirSeal® have a shorter mean operative time and decreased frequency and intensity of postoperative shoulder tip pain compared with patients undergoing surgery with standard pressure CO2 insufflation systems. It is the secondary objective of the trial to evaluate immunologic and anaesthesiological aspects of laparoscopic cholecystectomy, colorectal surgery and laparoscopic hernia repair by observing the immune responses and volume of mechanical ventilation of the two groups through measuring various immunologic factors and ventilation volume/CO2 elimination volume. Surgical side effects will also be measured as secondary objective.

Interventions

PROCEDURELaparoscopic surgery

Sponsors

Krankenhaus Barmherzige Schwestern Linz
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients recruited for laparoscopic surgery i.e. cholecystectomy, colorectal surgery, hernia repair * Written informed consent * ≥ 18 years of age

Exclusion criteria

* Patients with known immunological dysfunction (advanced liver disease, HIV, hepatitis C virus infection), drug addiction * ≤18 years of age * Pregnancy and lactation * Previous extensive abdominal surgery * Acute surgical intervention

Design outcomes

Primary

MeasureTime frameDescription
time of surgeryone yearTime of surgery, expressed in minutes from the time of incising to suturing the skin.
shoulder painone yearPostoperative shoulder tip pain assessed by the Visual Analogue Scale of Pain (VAS scale).

Secondary

MeasureTime frameDescription
Immunological aspectsone yearExamine changes in the concentration of certain cytokines and angiogenic factors serum levels in the early postoperative period after laparoscopic surgery procedures performed with AirSeal® versus standard- pressure CO2 pneumoperitoneum.
postoperative complicationsone yearHaemorrhage, Wound infections, Intra-abdominal abscess, Anastomotic leakage, Deep vein thrombosis, Pulmonary embolism

Other

MeasureTime frameDescription
Anaesthesiological aspectsone yearExamine intraoperative changes in ventilation volume, acid-base balance and CO2 elimination in patients undergoing laparoscopic surgery procedures performed with AirSeal® versus standard- pressure CO2 pneumoperitoneum.

Countries

Austria

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 7, 2026